Literature DB >> 7775451

Reduced chaperone-like activity of alpha A(ins)-crystallin, an alternative splicing product containing a large insert peptide.

R H Smulders1, I G van Geel, W L Gerards, H Bloemendal, W W de Jong.   

Abstract

alpha-Crystallin is a multimeric protein complex which is constitutively expressed at high levels in the vertebrate eye lens, where it serves a structural role, and at low levels in several non-lenticular tissues. Like other members of the small heat shock protein family, alpha-crystallin has a chaperone-like activity in suppressing nonspecific aggregation of denaturing proteins in vitro. Apart from the major alpha A- and alpha B-subunits, alpha-crystallin of rodents contains an additional minor subunit resulting from alternative splicing, alpha A(ins)-crystallin. This polypeptide is identical to normal alpha A-crystallin except for an insert peptide of 23 residues. To explore the structural and functional consequences of this insertion, we have expressed rat alpha A- and alpha A(ins)-crystallin in Escherichia coli. The multimeric particles formed by alpha A(ins) are larger and more disperse than those of alpha A, but they are native-like and display a similar thermostability and morphology, as revealed by gel permeation chromatography, tryptophan fluorescence measurements, and electron microscopy. However, as compared with alpha A, the alpha A(ins)-particles display a diminished chaperone-like activity in the protection of heat-induced aggregation of beta low-crystallin. Our experiments indicate that alpha A(ins)-multimers have a 3-4-fold reduced substrate binding capacity, which might be correlated to their increased particle size and to a shielding of binding sites by the insert peptides. The structure-function relationship of the natural mutant alpha A(ins)-crystallin may shed light on the mechanism of chaperone-like activity displayed by all small heat shock proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775451     DOI: 10.1074/jbc.270.23.13916

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Exon shuffling mimicked in cell culture.

Authors:  A A van Rijk; W W de Jong; H Bloemendal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function.

Authors:  M P Bova; O Yaron; Q Huang; L Ding; D A Haley; P L Stewart; J Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  The rodent alphaA-crystallin gene: mutagenesis of a non-consensus 5'-splice site to study alternative splicing in vivo.

Authors:  R H Smulders; B P Kokke; M L Gijsen; W W de Jong
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

Review 4.  Heat shock proteins: cellular and molecular mechanisms in the central nervous system.

Authors:  R Anne Stetler; Yu Gan; Wenting Zhang; Anthony K Liou; Yanqin Gao; Guodong Cao; Jun Chen
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

5.  Species-Specific Structural and Functional Divergence of α-Crystallins: Zebrafish αBa- and Rodent αA(ins)-Crystallin Encode Activated Chaperones.

Authors:  Hanane A Koteiche; Derek P Claxton; Sanjay Mishra; Richard A Stein; Ezelle T McDonald; Hassane S Mchaourab
Journal:  Biochemistry       Date:  2015-09-17       Impact factor: 3.162

6.  RETRACTED: Peptide-induced formation of protein aggregates and amyloid fibrils in human and guinea pig αA-crystallins under physiological conditions of temperature and pH.

Authors:  Anbarasu Kumarasamy; Sivakumar Jeyarajan; Jonathan Cheon; Anthony Premceski; Eric Seidel; Victoria A Kimler; Frank J Giblin
Journal:  Exp Eye Res       Date:  2018-11-15       Impact factor: 3.467

Review 7.  HSP27: mechanisms of cellular protection against neuronal injury.

Authors:  R A Stetler; Y Gao; A P Signore; G Cao; J Chen
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.